chartexchange

Dianthus Therapeutics to Participate in Five Investor Conferences During November

GlobeNewswire Inc. | Nov 2, 2026 4:01 PM EST

NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in five investor conferences.

Read original article